EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Oral propranolol and its impact on vital signs in hospitalized pediatric patients for the Management of Infantile Hemangiomas

Katelyn Rypka iD, Gretchen Bellefeuille, Zachary Wendland, Briana Paiewonsky, Rebecca Freese, Sheilagh Maguiness iD, Cynthia Nicholson

Pediatric Dermatology · 2025

DOI: 10.1111/pde.15740 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Dermatology, 2025. Verfasst von Katelyn Rypka und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, University of Minnesota, Minneapolis, Minnesota, USA. Hauptthemen laut MEDLINE: Propranolol, Vital Signs, Adrenergic beta-Antagonists, Skin Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NCATS NIH HHS, National Institutes of Health's National Center for Advancing Translational Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background Infantile hemangiomas (IH) affect 2%–10% of the pediatric population. The current standard treatment for complicated IH is oral propranolol. Propranolol initiation protocols vary depending on institution and may occur in an inpatient setting for patients

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PropranololVital SignsAdrenergic beta-AntagonistsSkin NeoplasmsHemangiomaHumansRetrospective StudiesInfantFemaleMaleAdministration, OralInfant, NewbornHospitalizationBlood PressureHeart RateAortic CoarctationEye AbnormalitiesNeurocutaneous Syndromes

Stichwörter der Autor:innen

PHACE syndromeblood pressureheart ratehospitalizationhypoglycemiainfantile hemangiomapropranololvital sign monitoring

Substanzen

PropranololAdrenergic beta-Antagonists

Autor:innen und Institutionen

  • Department of Dermatology, University of Minnesota, Minneapolis, Minnesota, USA.
  • Department of Dermatology, Minneapolis VA Medical Center, Minneapolis, Minnesota, USA.
  • Department of Internal Medicine, Florida Atlantic University Charles E. Schmidt College of Medicine, Boca Raton, Florida, USA.
  • Biostatistical Design and Analysis Center, Clinical and Translational Science Institute, University of Minnesota, Minneapolis, Minnesota, USA.
  • Department of Pediatric Dermatology, University of Minnesota, Minneapolis, Minnesota, USA.

ORCID-Profile: Katelyn Rypka, Sheilagh Maguiness

Förderung

  • NCATS NIH HHS
  • National Institutes of Health's National Center for Advancing Translational Sciences

Zitieren

APA

Rypka, K., Bellefeuille, G., Wendland, Z., Paiewonsky, B., Freese, R., Maguiness, S., & Nicholson, C. (2025). Oral propranolol and its impact on vital signs in hospitalized pediatric patients for the Management of Infantile Hemangiomas. Pediatric Dermatology. https://doi.org/10.1111/pde.15740

Vancouver

Rypka K, Bellefeuille G, Wendland Z, Paiewonsky B, Freese R, Maguiness S, et al. Oral propranolol and its impact on vital signs in hospitalized pediatric patients for the Management of Infantile Hemangiomas. Pediatric Dermatology. 2025. doi:10.1111/pde.15740

BibTeX
@article{Rypka2025,
  author = {Rypka, Katelyn and Bellefeuille, Gretchen and Wendland, Zachary and Paiewonsky, Briana and Freese, Rebecca and Maguiness, Sheilagh and Nicholson, Cynthia},
  title = {Oral propranolol and its impact on vital signs in hospitalized pediatric patients for the Management of Infantile Hemangiomas},
  journal = {Pediatric Dermatology},
  year = {2025},
  doi = {10.1111/pde.15740}
}
Kostenlos starten →